So you made a baseline correction and now the team discusses ANCOVA [General Sta­tis­tics]

posted by martin  – Austria, 2018-02-15 18:14 (2258 d 15:50 ago) – Posting: # 18424
Views: 4,602

Dear Everbody,

Dealing with endogenous compounds is tricky and here are some more thoughts you may find helpful

This could be considered as change from baseline problem and you may have a look at Stephen Senns work on this topic relating to ANCOVA (e.g. Statist. Med. 2006; 25:4334–4344. https://doi.org/10.1002/sim.2682 )

You may find also this article of interest addressing adjustment of endogenous levels in PK modeling: Bauer, A. & Wolfsegger, M.J. Eur J Clin Pharmacol (2014) 70: 1465. https://doi.org/10.1007/s00228-014-1759-x

Best regards & hope this helps

Martin

Complete thread:

UA Flag
Activity
 Admin contact
22,990 posts in 4,826 threads, 1,664 registered users;
66 visitors (1 registered, 65 guests [including 7 identified bots]).
Forum time: 11:05 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5